Omeros Corporation
Omeros Corporation, a biopharmaceutical company headquartered in the United States, is renowned for its innovative approach to drug development. Founded in 1994, Omeros has made significant strides in the fields of ophthalmology, immunology, and neurology, focusing on the discovery and commercialisation of novel therapeutics. The company’s flagship products, including the FDA-approved Omidria, exemplify its commitment to addressing unmet medical needs with unique formulations that enhance surgical outcomes. Omeros has established a strong market position, bolstered by its proprietary platform technologies and a robust pipeline of drug candidates. With a dedication to advancing patient care, Omeros continues to be a leader in the biopharmaceutical industry, driving forward with a vision of transformative therapies.
DitchCarbon Score
How does Omeros Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Omeros Corporation's score of 18 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Omeros Corporation's reported carbon emissions
Omeros Corporation, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of documented reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, Omeros Corporation may need to establish clear climate goals and reporting practices to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Omeros Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
